The Gx Elite vials have set new standards for type 1 borosilicate glass vials. They are the re-sult of comprehensive optimization measures in the conversion process, which have focused on designing out the risk to create product flaws during production including the removal of all glass-to-glass contact beginning with the tubing material all the way through final packaging. The chemical composition of the bo-rosilicate glass is still the same. Gerresheimer will be showcasing Gx Elite vials at booth D02 in Hall 4.2 at CPhI Worldwide in Frank-furt (Germany) from October 24 to 26, 2017.
"Our Gx Elite vials are setting new standards when it comes to quality," says Jens Heymann, Senior Vice President Europe & Asia Tubular Glass at Gerresheimer, underlining the major difference that avoiding glass-to-glass contact in the production process can have on vial quality. The highly shatter-resistant vials are extremely durable and free of cos-metic defects. They also boast an incredibly robust structure, while their resistance to delamination protects the drug inside. Simple handling and a range of packaging options ensure that Gx Elite vials can be supplied for end-to-end use on various filling lines. For customers, this means lower costs and higher quality.
Gx Elite vials are a step up from standard products, performing significantly better in compression and side impact tests.
All of Gerresheimer’s tubular glass plants that produce vials work with standardized monitoring, inspection, and packaging technologies, which essentially comprise the Gx G3 and Gx RHOC systems. The inspection systems, for one, are developed in house and form part of a close-knit testing system that ensures the highest precision and quality assurance in line with the latest standards. Complete with five HD cameras, the Gx G3 inspection system makes sure that cosmetic defects are identified reliably, for instance. The intelligent software detects and classifies the defects in a few fractions of a second, while the Gx RHOC system en-sures dimensional quality with three HD matrix cameras on each side and a hypercentric ID camera.
Injection vials set the benchmark for primary packaging for parenteral drugs. Gerresheimer’s vials come in all sizes and comply with the rele-vant international standards and pharmacopoeias (EU, USP, JP). The company’s range includes solutions for bioengineered drugs and other specialist pharmaceuticals.
More info: Tubular glass injection vials